XML 33 R6.htm IDEA: XBRL DOCUMENT v3.25.4
Consolidated Statements of Equity - USD ($)
$ in Thousands
Total
Public Offering
ATM Program
Common Stock
Common Stock
Public Offering
Common Stock
ATM Program
Additional Paid-in Capital
Additional Paid-in Capital
Public Offering
Additional Paid-in Capital
ATM Program
Distributions in Excess of Accumulated Net Income
Accumulated Comprehensive Income (Loss)
Balance beginning of period (in shares) at Dec. 31, 2022       67,472,553              
Balance beginning of period at Dec. 31, 2022 $ 1,603,909     $ 67     $ 5,456,968     $ (3,879,847) $ 26,721
Increase (Decrease) in Stockholders' Equity [Roll Forward]                      
Net income 5,269                 5,269  
  Unrealized (loss) gain on derivatives 6,228                   6,228
Reclassification from interest expense, net (14,875)                   (14,875)
Distributions declared (58,248)                 (58,248)  
Issuance of common stock under offering and ATM Program, net (in shares)           208,040          
Issuance of common stock under offering and ATM Program, net     $ 4,333           $ 4,333    
Stock-based compensation, net (in shares)       127,238              
Stock-based compensation, net 7,428     $ 1     7,427        
Balance end of period (in shares) at Dec. 31, 2023       67,807,831              
Balance end of period at Dec. 31, 2023 1,554,044     $ 68     5,468,728     (3,932,826) 18,074
Increase (Decrease) in Stockholders' Equity [Roll Forward]                      
Net income 13,658                 13,658  
  Unrealized (loss) gain on derivatives 9,019                   9,019
Reclassification from interest expense, net (12,667)                   (12,667)
Distributions declared (65,697)                 (65,697)  
Issuance of common stock under offering and ATM Program, net (in shares)         9,200,000 254,082          
Issuance of common stock under offering and ATM Program, net   $ 245,843 $ 7,620   $ 9     $ 245,834 $ 7,620    
Stock-based compensation, net (in shares)       188,881              
Stock-based compensation, net $ 8,185     $ 0     8,185        
Balance end of period (in shares) at Dec. 31, 2024 77,450,794     77,450,794              
Balance end of period at Dec. 31, 2024 $ 1,760,005     $ 77     5,730,367     (3,984,865) 14,426
Increase (Decrease) in Stockholders' Equity [Roll Forward]                      
Net income 111,421                 111,421  
  Unrealized (loss) gain on derivatives (807)                   (807)
Reclassification from interest expense, net (8,858)                   (8,858)
Distributions declared (73,785)                 (73,785)  
Stock-based compensation, net (in shares)       240,739              
Stock-based compensation, net $ 6,286     $ 1     6,285        
Balance end of period (in shares) at Dec. 31, 2025 77,691,533     77,691,533              
Balance end of period at Dec. 31, 2025 $ 1,794,262     $ 78     $ 5,736,652     $ (3,947,229) $ 4,761